Mirae Asset Global Investments’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-4,167
Closed -$60.5K 1628
2025
Q1
$60.5K Buy
+4,167
New +$64.1K ﹤0.01% 1207
2024
Q2
Sell
-19,613
Closed -$436K 2210
2024
Q1
$436K Sell
19,613
-33,598
-63% -$577K ﹤0.01% 1959
2023
Q4
$767K Sell
53,211
-43,244
-45% -$588K ﹤0.01% 1757
2023
Q3
$1.67M Sell
96,455
-13,871
-13% -$289K ﹤0.01% 1254
2023
Q2
$2.29M Buy
110,326
+36,568
+50% +$795K ﹤0.01% 1149
2023
Q1
$1.73M Buy
73,758
+33,668
+84% +$904K ﹤0.01% 1284
2022
Q4
$1.12M Buy
40,090
+2,710
+7% +$69.3K ﹤0.01% 1427
2022
Q3
$875K Buy
37,380
+116
+0.3% +$3.5K ﹤0.01% 1559
2022
Q2
$1.26M Buy
37,264
+18,510
+99% +$648K ﹤0.01% 1305
2022
Q1
$656K Buy
18,754
+4,973
+36% +$170K ﹤0.01% 1410
2021
Q4
$420K Sell
13,781
-25,367
-65% -$826K ﹤0.01% 1472
2021
Q3
$1.28M Buy
39,148
+20,108
+106% +$643K ﹤0.01% 1226
2021
Q2
$576K Buy
+19,040
New +$627K ﹤0.01% 1416

Other funds holding OGN

Mirae Asset Global Investments's OGN Position: Q2 2025 in Review

Mirae Asset Global Investments sold out of Organon & Co (OGN) in Q2 2025, closing a stake of 4,167 shares — an estimated $60.5K sold.

Mirae Asset Global Investments first reported a position in OGN in Q2 2021 and held it in 13 quarters. The position peaked at $2.29M in Q2 2023. 695 funds tracked by Wall St. Rank hold OGN as of Q2 2025.

  • Mirae Asset Global Investments reported no remaining Organon & Co position as of Q2 2025 after selling out during the quarter.
  • Mirae Asset Global Investments sold 4,167 Organon & Co shares in Q2 2025, an estimated $60.5K.
  • Mirae Asset Global Investments first reported a position in Organon & Co in Q2 2021 and held it in 13 quarters.
  • Mirae Asset Global Investments's Organon & Co position peaked at $2.29M in Q2 2023.
  • 695 funds tracked by Wall St. Rank held Organon & Co as of Q2 2025.

Based on Mirae Asset Global Investments's 13F filing for Q2 2025, filed 21 Jul 2025.